Overlake Medical Center is a 349-bed non-profit community hospital located in Bellevue, Washington. The hospital opened in 1960, and operates a level III emergency department.

There are 349 beds in Overlake Medical Center.

During the past decade, Overlake Medical Center conducted 125 clinical trials. In the 10-year time frame, 125 clinical trials started and 48 clinical trials were completed, i.e. on average, 38.4% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 38 clinical trials were completed. i.e. 88.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Overlake Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Abbott Medical Devices" with 12 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Overlake Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 75 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Overlake Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Breast Cancer" (5 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Overlake Medical Center" in a lesser frequency.

Most popular intervention types in "Overlake Medical Center" are "Drug" (119 trials), "Other" (89 trials), "Biological" (64 trials), "Procedure" (44 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (36 trials), "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "Overlake Medical Center" are 144 trials for "All" genders, 26 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Overlake Medical Center". undefined are not yet recruiting, 46 are recruiting, 68 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Overlake Medical Center, 6 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Overlake Medical Center, 3 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".

Overlake Medical Center has several departments that took part in Clinical trials: "Overlake Cancer Center at Overlake Hospital Medical Center" - 15 trials, "Overlake Internal Medicine Associates" - 5 trials